Siemens Marries AI Grid Blueprint with Share Repurchase as Stock Circles Highs

Siemens aggressively buys back shares while partnering Nvidia on industrial AI data centers; Healthineers trims growth forecast amid China weakness.

Siemens is playing both offense and defense. The Munich-based industrial group is refining the architecture of artificial intelligence data centers alongside Nvidia, while simultaneously buying back its own shares at a pace that signals deep management conviction. Trading at €270.70, the stock sits roughly 2% below its 52-week peak of €275.75 and has climbed 12.37% since the start of the year.

The buyback campaign has been relentless. Since launching a multi-billion-euro programme on 12 February 2024, Siemens has acquired 27.6 million of its own shares. In the final week of May alone, it bought 278,209 shares at prices between €271.02 and €276.01 — well above the 50-day moving average of €244.04. Each repurchase lifts earnings per share for remaining holders, a tactic analysts interpret as a clear vote of confidence from the board.

On the growth front, Siemens has unveiled a reference design for industrial-scale AI data centres developed jointly with Nvidia. The system is built for 136 megawatts of total capacity, of which 100 megawatts are dedicated to IT load. Battery storage comes from Fluence Energy, a company in which Siemens holds a major stake. The announcement lit a fire under Fluence stock, which recorded double-digit gains, underpinned by a record order backlog of $5.6 billion. By positioning itself as the system integrator between power infrastructure and high-performance computing, Siemens is targeting a core bottleneck in AI training: the need for stable, efficient electricity supply.

Meanwhile, the group has become the first software provider to sign a framework agreement with the European Chips Joint Undertaking. The initiative, dubbed EuroCDP — European Chips Design Platform — aims to strengthen semiconductor design and production across Europe. Siemens will supply the software tools for complex chip layouts, a strategically vital niche that often flies under the radar.

The picture is not uniformly bright. Siemens Healthineers, the medical technology subsidiary, has trimmed its revenue growth forecast for 2025/26 to 4.5% to 5.0%, down from an earlier target of up to 6.0%. Weakness in China’s laboratory diagnostics business and persistent cost inflation for memory chips and logistics are the main drags. Healthineers is running its own buyback programme of up to €230 million, scheduled to retire a maximum of 14 million shares by early 2027.

Analysts remain broadly constructive. Barclays keeps an “Overweight” rating on Healthineers with a €50 target. Goldman Sachs holds a €212 price target on Siemens Energy, arguing its operating profit could significantly exceed market consensus by 2030. JPMorgan is more bullish still, setting a €225 target, though it flags potential delays in AI infrastructure build-out as a tangible risk.

Germany’s broader industrial climate remains mixed. The manufacturing purchasing managers’ index has softened slightly, yet 31% of industrial companies now deploy artificial intelligence in production, according to a recent sector survey. Siemens is widely regarded as a frontrunner in that shift. With the DAX hovering near 25,083 points, tech heavyweights like SAP and Infineon continue to ride the AI wave, even as geopolitical jitters cap sentiment.

For now, the market is watching two signals: the pace of the buyback and the order intake from Siemens’ digital industries division. Official quarterly numbers are due this summer. Until then, the company is making its own case — both by buying its own stock and by helping build the infrastructure that powers the AI economy.